Blanca Hernando

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

Miguel Martín, Manuel Ruíz Borrego, Agustí Barnadas et al. · Journal of Clinical Oncology · 2013 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis

Miguel Martín, Noelia Martínez-Jáñez, Manuel Ramos et al. · The Oncologist · 2015 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection

Carolina Velázquez, Enrique Lastra, Francisco Avila Cobos et al. · Journal of Translational Medicine · 2020 · 19 citations · Full text

Life Sciences, Genetics, Oncology +17

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

Luís Manso, Cristina Hernándo, María Galán et al. · The Breast · 2020 · 14 citations · Full text

Medicine, Oncology, Pharmacology +16

Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype

Virginia Lope, Ángel Guerrero‐Zotano, Ana Casas et al. · Nutrients · 2020 · 12 citations · Full text

Life Sciences, Biochemistry, Oncology +17